Spotlight on Bevacizumab in Metastatic Colorectal Cancer

ISSN： 1173-8804

Source： BioDrugs, Vol.22, Iss.5, 2008-01, pp. : 339-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Panitumumab in Metastatic Colorectal Cancer†

By Keating Gillian M.

BioDrugs, Vol. 24, Iss. 4, 2010-08 ,pp. : 275-278

Adis International

Access to resources Recommend Favorite

Spotlight on Bevacizumab in Advanced Colorectal Cancer, Breast Cancer, and Non-Small Cell Lung Cancer

By Lyseng-Williamson Katherine A. Robinson Dean M.

BioDrugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 193-195

Adis International

Access to resources Recommend Favorite

Optimizing the Efficacy of First-Line Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: Analysis of Multiple Methods

By Li Shaotang

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 43-50

Adis International

Access to resources Recommend Favorite

Panitumumab: In Metastatic Colorectal Cancer with Wild-Type KRAS

By Weber Juliane McCormack Paul L.

BioDrugs, Vol. 22, Iss. 6, 2008-01 ,pp. : 403-411

Adis International

Access to resources Recommend Favorite